Antoinette Radford,Maureen

Antoinette Radford is a breaking news writer with extensive experience in covering international and domestic events for reputable organizations. She currently works for CNN Digital's Live News Team in London, where she provides real-time updates and analysis on various topics such as the war in Ukraine, Israel-Hamas war, and US politics. Prior to joining CNN, Radford was part of BBC News, where she covered significant breaking news stories including the Ukraine war, wildfires in Hawaii, elections across Europe and riots in France. She has also worked for public broadcasting in her home country of Australia at both the Australian Broadcasting Corporation and Special Broadcasting Service. While at ABC, Radford covered a high-profile court case involving an alleged rape of a staffer inside Parliament House. Her areas of interest include covering Australia, environmental issues and conservation, as well as geopolitics with a focus on the European and Pacific regions. She is fluent in French and Spanish.

99%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Supreme Court Upholds FDA Approval of Abortion Pill Mifepristone, Preserving Access for Now

Supreme Court Upholds FDA Approval of Abortion Pill Mifepristone, Preserving Access for Now

Broke On: Thursday, 13 June 2024 The Supreme Court unanimously upheld the FDA's approval of mifepristone, preserving nationwide access to the abortion pill. The ruling sets a precedent against judges limiting patient access to critical medications and politicizing the FDA's approval process. Mifepristone, a safe and effective drug used in combination with misoprostol for medication abortions, remains crucial for many people in states with limited clinic access. Challenges to reproductive health care continue as anti-abortion groups seek further restrictions.